keyword
https://read.qxmd.com/read/38645429/overview-of-the-expression-patterns-and-roles-of-lipocalin-2-in-the-reproductive-system
#1
REVIEW
Marinela Krizanac, Paola Berenice Mass Sanchez, Ralf Weiskirchen, Sarah K Schröder
The 25 kDa-sized protein Lipocalin 2 (LCN2) was originally isolated from human neutrophil granulocytes more than 30 years ago. LCN2 is an emerging player in innate immune defense, as it reduces bacterial growth due to its ability to sequester iron-containing bacterial siderophores. On the other hand, LCN2 also serves as a transporter for various hydrophobic substances due to its β-barrel shaped structure. Over the years, LCN2 has been detected in many other cell types including epithelial cells, astrocytes, and hepatocytes...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38642018/exploring-raloxifene-based-metallodrugs-a-versatile-vector-combined-with-pt-ii-palladium-ii-and-nickel-ii-dichlorides-and-carborates-against-triple-negative-breast-cancer
#2
JOURNAL ARTICLE
Aleksandr Kazimir, Tom Götze, Peter Lönnecke, Blagoje Murganić, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Triple-negative breast cancer (TNBC) poses challenges in therapy due to the absence of target expression such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Frequently, the treatment of TNBC involves the combination of several therapeutics. However, an enhanced therapeutic effect can be also achieved within a single molecule. The efficacy of raloxifene can be improved by designing a raloxifene-based hybrid drug bearing a 2,2'-bipyridine moiety (2)...
April 20, 2024: ChemMedChem
https://read.qxmd.com/read/38635933/genomic-landscape-of-circulating-tumor-dna-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-metastatic-breast-cancer-treated-with-abemaciclib-data-from-the-scrum-japan-cancer-genome-screening-project
#3
JOURNAL ARTICLE
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
PURPOSE: To understand the mutational landscape of circulating tumor DNA (ctDNA) and tumor tissue of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (MBC) treated with abemaciclib + endocrine therapy (ET). METHODS: Blood samples for ctDNA and/or tissue samples were collected from abemaciclib-treated patients with HR+/HER2- MBC enrolled in the SCRUM-Japan MONSTAR-SCREEN project. Blood samples were collected before abemaciclib initiation (baseline) and at disease progression/abemaciclib discontinuation (post abemaciclib treatment)...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38630308/growth-after-pediatric-kidney-transplantation-a-25-year-study-in-a-pediatric-kidney-transplant-center
#4
JOURNAL ARTICLE
Ana Raquel Claro, Ana Rita Oliveira, Filipa Durão, Patrícia Costa Reis, Ana Rita Sandes, Carla Pereira, José Esteves da Silva
OBJECTIVES: Growth failure is one of the major complications of pediatric chronic kidney disease. Even after a kidney transplant (KT), up to 50 % of patients fail to achieve the expected final height. This study aimed to assess longitudinal growth after KT and identify factors influencing it. METHODS: A retrospective observational study was performed. We reviewed the clinical records of all patients who underwent KT for 25 years in a single center (n=149) and performed telephone interviews...
April 18, 2024: Journal of Pediatric Endocrinology & Metabolism: JPEM
https://read.qxmd.com/read/38621588/space-research-to-explore-novel-biochemical-insights-on-earth
#5
REVIEW
Simona Ferraro, Anilkumar Dave, Cristina Cereda, Elvira Verduci, Santica Marcovina, Gianvincenzo Zuccotti
Travel to space has overcome unprecedent technological challenges and this has resulted in transfer of these technological results on Earth to better our lives. Health technology, medical devices, and research advancements in human biology are the first beneficiaries of this transfer. The real breakthrough came with the International Space Station, which endorsed multidisciplinary international scientific collaborations and boosted the research on pathophysiological adaptation of astronauts to life on space...
April 13, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38621496/genomic-insights-into-key-genes-and-qtls-involved-in-cattle-reproduction
#6
REVIEW
Manjit Panigrahi, Divya Rajawat, Sonali Sonejita Nayak, Karan Jain, Ayushi Vaidhya, Ravi Prakash, Anurodh Sharma, Subhashree Parida, Bharat Bhushan, Triveni Dutt
In an economic context, reproductive characteristics are fundamental for sustainable production, particularly for monotocous livestock like cattle. An inter-calving interval is indicative of low reproductive capacity. This issue changes the dynamics of current and future lactations since it necessitates more inseminations, veterinary care, and hormone interventions. Various reproductive phenotypes, including ovulation, mating, fertility, pregnancy, embryonic growth, and calving-related traits, are observed in dairy cattle and these traits have been associated with several QTLs...
April 13, 2024: Gene
https://read.qxmd.com/read/38606163/hr-positive-her2-negative-breast-cancer-arising-in-patients-with-or-without-brca2-mutation-different-biological-phenotype-and-similar-prognosis
#7
JOURNAL ARTICLE
Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao
BACKGROUND: BRCA2 plays a key role in homologous recombination. However, information regarding its mutations in Chinese patients with breast cancer remains limited. OBJECTIVES: This study aimed to assess the clinicopathological characteristics of BRCA2 mutation breast cancer and explore the mutation's effect on hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer survival in China. DESIGN: This hospital-based cohort study prospectively included 629 women with breast cancer diagnosed from 2008 to 2023 at Zhejiang Cancer Hospital in China...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38603658/real-world-evidence-of-ribociclib-plus-aromatase-inhibitors-as-first-line-treatment-in-advanced-breast-cancer-the-brasileeira-study
#8
JOURNAL ARTICLE
Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, Flavia Rocha Paes, André Mattar, Jorge H Santos Leal, Sérgio D Simon, Ellias Magalhães Abreu Lima, Gustavo Werutsky, Gustavo H Munhoz Piotto, José Bines, Lucas Petri Damiani, Ariane Macedo, Lígia Campos, Anna Maria Buehler
PURPOSE: Cyclin inhibitors plus endocrine therapy represent the reference standard for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer (ABC). Efficacy results on hard end points such as overall survival come from well-designed randomized clinical trials (RCTs). However, a limitation of RCTs is the low external results validity, and their extrapolation to a broader population may not be appropriate. Real-world studies can overcome these limitations, also increasing the reliability of RCTs...
April 2024: JCO global oncology
https://read.qxmd.com/read/38580842/glucose-regulatory-hormones-and-growth-in-very-preterm-infants-fed-fortified-human-milk
#9
JOURNAL ARTICLE
Kristine Holgersen, Martin Bo Rasmussen, Itay Zamir, Lise Aunsholt, Gitte Zachariassen, Per Torp Sangild
BACKGROUND: Bovine colostrum (BC) contains a range of milk bioactive components, and it is unknown how human milk fortification with BC affects glucose-regulatory hormones in very preterm infants (VPIs). This study aimed to investigate the associations between hormone concentrations and fortification type, birth weight (appropriate/small for gestational age, AGA/SGA), milk intake, postnatal age, and body growth. METHODS: 225 VPIs were randomized to fortification with BC or conventional fortifier (CF)...
April 5, 2024: Pediatric Research
https://read.qxmd.com/read/38578394/population-pharmacokinetics-of-sacituzumab-govitecan-in-patients-with-metastatic-triple-negative-breast-cancer-and-other-solid-tumors
#10
JOURNAL ARTICLE
Abhishek G Sathe, Indrajeet Singh, Pratap Singh, Paul M Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui, See Phan, Sandhya Girish, Ahmed A Othman
BACKGROUND AND OBJECTIVE: Sacituzumab govitecan (SG) is an antibody-drug conjugate composed of an antibody with affinity for Trop-2 coupled to SN-38 via hydrolyzable linker. SG is approved for patients with metastatic triple-negative breast cancer (mTNBC) who have received two or more prior chemotherapies (at least one in a metastatic setting) and for patients with pretreated hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer...
April 5, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38576283/genotypic-frequency-of-rh-cw-antigen-in-blood-donors-of-northern-pakistan
#11
JOURNAL ARTICLE
Sarah Fatimah, Asad Mahmood Abbasi, Ali Abbasi, Nargis Sabir, Rozina Ghani, Rehan Ahmed Khan Lodhi
OBJECTIVE: To determine the genotypic frequency of Rh Cw antigen in blood donors of Northern Pakistan. STUDY DESIGN: Descriptive cross-sectional study. Place and Duration of the Study: Department of Molecular Haematology, Armed Forces Institute of Transfusion (AFIT), Rawalpindi, Pakistan, from August 2022 to January 2023. METHODOLOGY: Blood donors were randomly selected. Venous blood samples were taken in K3-EDTA anticoagulant tubes. ABO and Rh D grouping were performed conventionally...
April 2024: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/38573759/comparison-of-the-real-world-reporting-of-symptoms-and-well-being-for-the-her2-directed-trastuzumab-biosimilar-ogivri-with-registry-data-for-herceptin-in-the-treatment-of-breast-cancer-prospective-observational-study-ogipro-of-electronic-patient-reported-outcomes
#12
JOURNAL ARTICLE
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu
BACKGROUND: Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs)...
April 4, 2024: JMIR Cancer
https://read.qxmd.com/read/38564683/adjuvant-chemotherapy-in-premenopausal-patients-with-hormone-positive-breast-cancer-with-a-recurrence-score-of-16-25-a-retrospective-analysis-using-the-national-cancer-database
#13
JOURNAL ARTICLE
Prashanth Ashok Kumar, Dongliang Wang, Danning Huang, Abirami Sivapiragasam
PURPOSE: Results from the TAILORx trial revealed that the use of adjuvant chemotherapy along with endocrine therapy had no survival advantage in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative (HER2-), node-negative (N0) breast cancer (BC) with an intermediate (11-25) 21-gene recurrence score (RS) in the overall population. However, in patients under age 50 years, adjuvant chemotherapy demonstrated a progression-free survival benefit when the RS ranged from 16-25...
March 2024: JCO Precision Oncology
https://read.qxmd.com/read/38557309/long-term-effect-of-growth-hormone-on-sleep-disordered-breathing-in-malaysian-children-with-prader-willi-syndrome-a-retrospective-study
#14
JOURNAL ARTICLE
Yee Ting Tan, Mohamad Shafiq Azanan, Shih Ying Hng, Kah Peng Eg, Muhammad Yazid Jalaludin, Meow Keong Thong, Sok Kun Tae, Nurshadia Samingan, Azriyanti Anuar, Anna Marie Nathan
STUDY OBJECTIVES: The effect of recombinant human growth hormone (rhGH) on sleep-disordered breathing (SDB) in Malaysian children with Prader-Willi syndrome (PWS) is under-investigated. We determined (a) the short- and long-term effects of rhGH and (b) factors associated with worsening SDB, in children with PWS on rhGH. METHODS: This retrospective study included children with PWS (with and without rhGH) who had at least one polysomnography (PSG). Outcomes measured were the presence of SDB: before and after starting rhGH and the progress of SDB with and without rhGH...
April 1, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38556315/-regulation-of-aging-processes-a-perspective-of-dietary-restriction-models
#15
JOURNAL ARTICLE
Isao Shimokawa
The moderate restriction of dietary energy intake (dietary restriction: DR) extends the lifespan and health span of various laboratory animals, suggesting that it delays the aging process inherent in many animal species. Attenuated growth hormone and insulin-like growth factor-1 (IGF-1) signaling caused by mutations also increases the lifespan of mice, even those allowed to feed freely. In nematodes, the Daf16, mammalian Forkhead box O (FoxO) transcription factor, was shown to be required for lifespan extension in response to reduced IGF-1 signaling...
2024: Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan
https://read.qxmd.com/read/38546943/palbociclib-in-older-patients-with-advanced-metastatic-breast-cancer-a-systematic-review
#16
Etienne Brain, Connie Chen, Sofia Simon, Vinay Pasupuleti, Kathleen Vieira Pfitzer, Karen A Gelmon
BACKGROUND: Palbociclib in combination with endocrine therapy is approved for treatment of hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer. In addition to clinical trials, several real-world studies have evaluated the effectiveness of palbociclib. With increased life expectancy in the general population, breast cancer in older women is also expected to increase. OBJECTIVE: The aim was to systematically review evidence from both clinical trials and real-world studies for palbociclib treatment outcomes in older patients with HR+/HER2- advanced/metastatic breast cancer (a/mBC)...
March 28, 2024: Targeted Oncology
https://read.qxmd.com/read/38539974/effect-of-day-length-on-growth-and-gonadal-development-in-meishan-male-pigs
#17
JOURNAL ARTICLE
Naisheng Lu, Hao Yuan, Xueyuan Jiang, Hulong Lei, Wen Yao, Peng Jia, Dong Xia
Day length is a critical environmental factor for regulating animal growth and development. This study aimed to investigate the effects of different day lengths on the developmental changes of growth parameters, testicular sizes, testosterone secretion in Meishan male pigs, and steroidogenesis proteins and melatonin receptors. Fourteen Meishan male pigs (10 weeks (wks) of age) with the same parity, paired in litter and body weight (BW), were evenly allocated into a short-day-length group (SDL, 10 light/14 dark) and long-day-length group (LDL, 14 light/10 dark)...
March 13, 2024: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38539179/association-of-hormone-receptors-and-human-epidermal-growth-factor-receptor-2-neu-expressions-with-clinicopathologic-factors-of-breast-carcinoma-a-cross-sectional-study-in-a-tertiary-care-hospital-kabul-afghanistan
#18
JOURNAL ARTICLE
Esmatullah Esmat, Ahmed Maseh Haidary, Ramin Saadaat, Syeda Naghma Rizvi, Syeda Aleena, Mujtaba Haidari, Sayed Murtaza Sadat Hofiani, Nasrin Hussaini, Ahmadullah Hakimi, Abdullatif Khairy, Jamshid Abdul-Ghafar
BACKGROUND: Breast cancer (BC) is one of the major causes of death worldwide. It is the most common cause of death before the age of 70 years. The incidence and mortality of BC are rapidly increasing, posing great challenges to the health system and economy of every nation. METHODOLOGY: A cross-sectional analytical study was conducted at the Department of Pathology and Clinical Laboratory of the French Medical Institute for Mothers and Children (FMIC) to demonstrate the association of human epidermal growth factor receptor 2 (Her2/Neu) and estrogen receptor (ER)/ progesterone receptor (PR) with clinical as well as pathological parameters among women with BC...
March 27, 2024: BMC Cancer
https://read.qxmd.com/read/38538719/comparative-metabolomics-reveals-serum-metabolites-changes-in-goats-during-different-developmental-stages
#19
JOURNAL ARTICLE
Qing Li, Tianle Chao, Yanyan Wang, Rong Xuan, Yanfei Guo, Peipei He, Lu Zhang, Jianmin Wang
Goats can provide meat, milk and skins for humans and are livestock with high economic benefits. However, despite their economic significance, the comprehensive analysis of goats' serum metabolic profile and its intricate alterations throughout their developmental journey remains conspicuously absent. To investigate the stage-specificity and dynamic change characteristics of metabolites during the growth and development of goats, this study compared the alterations in serum hormone levels and serum biochemical markers across different developmental stages of female goats (1, 60, 120 and 180 days old; n = 5)...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38536033/treatment-outcomes-in-older-patients-with-metastatic-breast-cancer-receiving-palbociclib-plus-an-aromatase-inhibitor-a-plain-language-summary
#20
REVIEW
Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Hope S Rugo
WHAT IS THIS SUMMARY ABOUT?: This summary describes an article published in the medical journal Frontiers in Oncology in September 2023. The article reports results from a study that looked at breast cancer treatments for older patients aged 75 years or older. The study focused on a type of cancer called HR+/HER2- metastatic breast cancer. HR+/HER2- stands for hormone receptorpositive/human epidermal growth factor receptor 2-negative. This study evaluated whether older patients with this type of cancer benefited from the combination of two medicines - palbociclib and an aromatase inhibitor - compared with taking an aromatase inhibitor alone...
March 27, 2024: Future Oncology
keyword
keyword
96119
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.